130

Pill imprint 130 has been identified as Mycophenolate mofetil 250 mg.

Mycophenolate mofetil is used in the treatment of organ transplant, rejection prophylaxis; nephrotic syndrome; inflammatory bowel disease; graft-versus-host disease; ulcerative colitis (and more), and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy.

Mycophenolate mofetil 250 mg is not subject to the Controlled Substances Act.
See also related documents.

Mycophenolate mofetil Images

Imprint:
130
Strength:
250 mg
Color:
Blue & White
Size:
19.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Inactive Ingredients:
silicon dioxide colloidal
croscarmellose sodium
FD&C Blue No. 1
FD&C Red No. 3
gelatin
magnesium stearate
povidone k90
pregelatinized corn starch
sodium lauryl sulfate
titanium dioxide
Drug Class:
Selective immunosuppressants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Zydus Pharmaceuticals
National Drug Code (NDC):
68382-0130
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
68084-0177 Amerisource Health Services

Note: Inactive ingredients may vary.

View Drug DetailsPrint Page

Mycophenolate mofetil 250 mg 130
Advertisement
Search Again

Search by Imprint, Shape or Color

Note: All fields optional. Use the pill finder to identify medications by visual appearance or name.

Imprint:
Color:
Shape:

Search by Drug Name

Drug Name:

Search by National Drug Codes (NDC)

Did you find this page helpful? Yes No

(web5)